MEETING
18 Nov 2024
ISCIII, Ernest Lluch Room
form 09:30 to 18:00
WELCOME
OPENING WELCOME SESSION
Authorities TBC
KEYNOTE LECTURE
THE ALL OF US RESEARCH PROGRAM: SUCCESSFUL US PRECISION MEDICINE STORY
Chairman: Rosario Perona Abellón (Deputy Director on Cell therapy and Regenerative Medicine, Instituto de Salud Carlos III)
Sheri Schully Ph.D. Deputy Chief Medical and Scientific Officer, All of Us Research Program. National Institutes oh Health
Melissa Basford MBA, Senior Director, Big Data Support Services, Vanderbilt Institute for Clinica and Translational Research (VICTR) – and Genomics Principal Investigator, All of Us Research Program. National Institutes of Health
Coffee & Networking
PRESENTATION OF ACHIEVEMENTS IN THE THREE IMPaCT AXES
Chairman: Fernando Rodríguez Artalejo (Universidad Autónoma de Madrid)
Beatriz Pérez-Gómez. (Axe 1 IMPaCT-Cohort Coordinator. Centro Nacional de Epidemiología, Instituto de Salud Carlos III)
Alfonso Valencia Herrera. (Axe 2 IMPaCT-Data Coordinator. Barcelona Supercomputing Center.
Ángel Carracedo Álvarez. (Axe 3 IMPaCT-Genomics Coordinator. Fundación Pública Gallega de Medicina Genómica)
ROUND TABLE 1
PERSONALIZED MEDICINE PROJECTS 2021: PRESENTATION OF RESULTS
Chairman: Joaquin Dopazo (Hospital Virgen del Rocío, Fundación Progreso y Salud)
Javier Corral de la Calle (Instituto Murciano de Investigación Biosanitaria (IMIB)). 4th generation sequencing with nanopores in the diagnosis of genetic diseases.
Pablo Lapunzina Badia (Instituto de Genética Médica y Molecular (INGEMM). Hospital Universitario La Paz) ONTOPREC.
Aroa Soriano Fernández (Instituto de Investigación Vall d´Hebron (VHIR)) SEHOP-PENCIL.
Dolores Corella Piquer. (Universidad de Valencia) Advances in precision medicine for obesity: Multiomic and dynamic analysis for the discovery and validation of biomarkers predicting weight loss after intervention in high-risk individuals.
ROUND TABLE 2
WORK OF THE COMMITTEES
Chairman: David Velasco Gail (S.G. Terapia Celular y Medicina Regenerativa, Instituto de Salud Carlos III)
Pilar Nicolás Jiménez (Universidad del País Vasco)
Pedro Carrascal Rueda (Plataforma de Organizaciones de Pacientes)
Daniel de Vicente Corbeira (Federación Española de Enfermedades Raras)
Inés Ortega Villanueva (Centro de Investigación Biomédica en Red)
José Antonio Plaza Ramos (Unidad de Apoyo a Dirección, Instituto de Salud Carlos III)
Lunch & Networking
The role of internationalization on IMPaCT
Chairman: Daniel Ruíz Iruela (Deputy Director for International Research Programs and Institutional Relations, Instituto de Salud Carlos III)
Elena Doménech Cruz (S.G. Programas Internacionales de Investigación y Relaciones Institucionales, Instituto de Salud Carlos III)
Marta Marín Barba (NCP «Cluster 1-Salud Horizonte Europa» y NCP «EIC Pathfinder y Transition Horizonte Europa» Oficina Europea, Fundación Española para la Ciencia y la Tecnología)
Juan Arenas Márquez (Head of ELIXIR Project Management Office and European Genomic Data Infrastructure Deployment)
Salvador Capellá-Guitierrez (Leader of the Spanish National Bioinformatics Institute (INB) at the Barcelona Supercomputing Center (BSC))
ROUND TABLE 3
PERSONALIZED MEDICINE PROJECTS 2022: PRESENTATION OF RESULTS
Chairman: Isabel Cuesta (Unidad Bioinformática, Instituto de Salud Carlos III)
Enrique de Alava Casado (Hospital Universitario Virgen del Rocío) Immune4ALL. Exploring the feasibility of predictive and pharmacodynamic biomarkers for immunotherapy in solid tumors.
Ángeles Almeida Parra (Instituto de Investigación Biomédica de Salamanca (IBSAL)) Personalized Medicine (MedPer) in the early detection of preclinical cognitive impairment (CD). Development of a predictive risk model.
Jesús Oteo Iglesias (Centro Nacional de Microbiología, Instituto de Salud Carlos III) Precision medicine against antimicrobial resistance: MePRAM Project.
Maria Molina Molina (Instituto de Investigación Biomédica de Bellvitge (IDIBELL)) Integration of molecular, genomic, morphological, and environmental features to improve precision diagnosis and treatment in Diffuse Fibrosing Interstitial Lung Diseases (Precision-ILD).
Teresa Padró Campany (Instituto de Investigación Sant Pau (IIB-Sant Pau)) Precision Medicine in Familial Hypercholesterolemia and Premature Cardiovascular Disease by Integrating Omics and Imaging Technologies (MedPreHF).
MAIN COMCLUSIONS AND CLOSURE
TBC